Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China.

Li Q, Liu M, Liu Y, Shi F, Yuan S, Di G, Jin H, Shi Y, Zhang W, Yang Z

Open source

DOI
10.1159/000538429
Published
2024 Jan-Dec
Container
Case reports in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000538429,
  title = {Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China.},
  author = {Li Q and Liu M and Liu Y and Shi F and Yuan S and Di G and Jin H and Shi Y and Zhang W and Yang Z},
  year = {2024},
  journal = {Case reports in oncology},
  doi = {10.1159/000538429},
  url = {https://doi.org/10.1159/000538429}
}

RIS

TY  - JOUR
TI  - Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China.
AU  - Li Q
AU  - Liu M
AU  - Liu Y
AU  - Shi F
AU  - Yuan S
AU  - Di G
AU  - Jin H
AU  - Shi Y
AU  - Zhang W
AU  - Yang Z
PY  - 2024
JO  - Case reports in oncology
DO  - 10.1159/000538429
UR  - https://doi.org/10.1159/000538429
ER  - 

APA

Q, L., M, L., Y, L., F, S., S, Y., G, D., H, J., Y, S., W, Z., & Z, Y. (2024). Lethal Immune-Related Pneumonitis after Durvalumab Therapy for Small Cell Lung Cancer: A First Case in China.. Case reports in oncology. https://doi.org/10.1159/000538429

Source records